Lise Jamieson
Lise Jamieson is a leading researcher in the field of HIV prevention and epidemiology. She is known for her work on modeling the impact of new HIV prevention strategies, including the use of long-acting injectables, to reduce new infections, particularly among high-risk populations. Her research aims to inform public health policies and programmatic decisions to effectively combat the HIV epidemic.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| South Africa | 2 | 7.00 | 0.89% | +0% | 59,308,690 | 527,188 | $350,000 | 3,111$ |
| Totals | 2 | 59,308,690 | 527,188 | $350,000 | 3,111$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
South Africa:
Lise Jamieson headed the study presented at the meeting discussing the allocation of lenacapavir shots.
7
South Africa:
Lise Jamieson is a modelling scientist at the Health Economics and Epidemiology Research Office at Wits University.
7
South Africa:
Lise Jamieson is HE2RO’s lead modeller discussing the distribution of the anti-HIV jab.
6
South Africa:
Lise Jamieson is the lead study author discussing the need for high numbers on the daily HIV prevention pill.
7